IP Library Granted Patent US 12,310,892
Granted Patent B2
US 12,310,892 · App. 17/941,307 · Granted May 27, 2025

Methods and devices for increasing aqueous drainage of the eye

Inventors: Tsontcho Ianchulev (Harrison, NY); David Robson (Harrison, NY)
Assignee: Iantrek, Inc.
A61F9/00781A61F2210/0014A61F2240/001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,310,892
App. No.
17/941,307
Granted
May 27, 2025
Kind
B2
Abstract

A device for disrupting tissue in an eye including a distal portion sized and configured for ab interno insertion into an anterior chamber of the eye having an elongate, flexible shaft of super-elastic memory-shape material. A distal end region is shaped into a curve having a radially inner surface connected to a radially outer surface by two lateral sides. The device has a tissue disruptor proximal of a distal-most end formed on at least one of the inner surface and the outer surface. The distal face of the tissue disruptor is a blunt tissue-engaging surface without any cutting element. Related methods and devices are provided.

Claims (24)

1. A device for disrupting tissue in an eye, the device comprising:

a distal portion sized and configured for ab interno insertion into an anterior chamber of the eye, the distal portion comprising:

an elongate, flexible shaft of super-elastic memory-shape material comprising:

a distal end region shaped into a curve having a central plane, wherein a radially inner surface is connected to a radially outer surface by two lateral sides;

a distal-most end; and

a tissue disruptor proximal of the distal-most end formed on at least one of the inner surface and the outer surface, wherein the tissue disruptor has a distal face, a proximal face, and a maximum thickness, the distal face sloping from a first thickness of the shaft distal to the tissue disruptor towards the maximum thickness and the proximal face tapering down from the maximum thickness to a second thickness of the shaft proximal to the tissue disruptor, wherein the first thickness, the maximum thickness, and the second thickness are each between the inner and outer surfaces, and

wherein the distal face of the tissue disruptor is a blunt tissue-engaging surface without any cutting element.

2. The device of claim 1 , wherein the distal-most end is a smooth ball tip.

3. The device of claim 2 , wherein the smooth ball tip is configured for circumferential gonio-traction.

4. The device of claim 2 , wherein the smooth ball tip on the shaft is located 1 mm-3 mm away from the distal face.

5. The device of claim 1 , wherein the tissue disruptor comprises a first tissue disruptor formed on the inner surface and a second tissue disruptor formed on or adjacent to the outer surface opposite the first tissue disruptor.

6. The device of claim 1 , further comprising a proximal housing having an introducer tube projecting from a distal end region of the housing, at least a portion of the shaft extending through a lumen of the introducer tube.

7. The device of claim 6 , wherein the shaft is configured to be advanced from the introducer tube.

8. The device of claim 7 , wherein the shaft develops a spring-load as the shaft extends from the introducer tube.

9. The device of claim 7 , wherein the shaft applies a radially outward force as the shaft extends from the introducer tube.

10. The device of claim 6 , wherein the introducer tube is a substantially rigid tube having a proximal end region that extends away from the proximal housing along a longitudinal axis and a distal end region that curves relative to the longitudinal axis.

11. The device of claim 10 , wherein the distal end region of the introducer tube has a first curved region and a second curved region, wherein the first curved region curves in a first direction at a first radius of curvature and the second curved region curves in a second direction at a second radius of curvature.

12. The device of claim 11 , wherein the first radius of curvature is greater than the second radius of curvature.

13. The device of claim 1 , wherein the first thickness of the shaft between the inner and outer surfaces proximal to the disruptor is 100-2000 microns and the second thickness of the shaft between the inner and outer surfaces distal to the disruptor is 100-550 microns.

14. The device of claim 13 , wherein the maximum thickness of the tissue disruptor between the inner and the outer surfaces is about 450-600 microns.

15. The device of claim 1 , wherein the shaft has a cross-sectional shape taken transverse to a length of the shaft between that is non-circular.

16. The device of claim 15 , wherein the cross-sectional shape is square or rectangular.

17. The device of claim 1 , wherein the curve of the distal end region of the shaft has a radial curvature of 5-20 mm.

18. The device of claim 1 , wherein the shaft has a length sufficient to be advanced around 30-360 degrees of a circumference of an eye.

Assignments (2)
SECURITY INTEREST Recorded Apr 15, 2026
From: IANTREK, INC.
To: TRINITY CAPITAL INC., AS COLLATERAL AGENT
Reel/Frame 075423/0518 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2024
From: IANCHULEV, TSONTCHO; ROBSON, DAVID
To: IANTREK, INC.
Reel/Frame 066825/0391 →
Continuity (4)
Provisional Application 63344443 · May 20, 2022
Provisional Application 63254436 · Oct 11, 2021
Provisional Application 63242856 · Sep 10, 2021
Related Publication 20230082713A1 · Mar 16, 2023
References Cited (102)
US 5437678A · Sorensen · 1995 [cited by applicant]
US 6979328B2 · Baerveldt et al. · 2005 [cited by applicant]
US 7207980B2 · Christian et al. · 2007 [cited by applicant]
US 7465310B2 · Isogimi · 2008 [cited by applicant]
US 7699882B2 · Stamper et al. · 2010 [cited by applicant]
US 7785321B2 · Baerveldt et al. · 2010 [cited by applicant]
US 7842034B2 · Mittelstein et al. · 2010 [cited by applicant]
US 7959641B2 · Sorensen et al. · 2011 [cited by applicant]
US 7967772B2 · McKenzie et al. · 2011 [cited by applicant]
US 8034105B2 · Stegmann et al. · 2011 [cited by applicant]
US 8123729B2 · Yamamoto et al. · 2012 [cited by applicant]
US 8172830B2 · Christian et al. · 2012 [cited by applicant]
US 8267882B2 · Euteneuer et al. · 2012 [cited by applicant]
US 8348924B2 · Christian et al. · 2013 [cited by applicant]
US 8425473B2 · Ho et al. · 2013 [cited by applicant]
US 8491549B2 · Conston et al. · 2013 [cited by applicant]
US 8512321B2 · Baerveldt et al. · 2013 [cited by applicant]
US 8529494B2 · Euteneuer et al. · 2013 [cited by applicant]
US 8721656B2 · De Juan, Jr. et al. · 2014 [cited by applicant]
US 8894603B2 · Badawi et al. · 2014 [cited by applicant]
US 9066783B2 · Euteneuer et al. · 2015 [cited by applicant]
US 9095412B2 · Badawi et al. · 2015 [cited by applicant]
US 9107729B2 · Sorensen et al. · 2015 [cited by applicant]
US 9216109B2 · Badawi et al. · 2015 [cited by applicant]
US 9226850B2 · Baerveldt et al. · 2016 [cited by applicant]
US 9358155B2 · Sorensen et al. · 2016 [cited by applicant]
US 9693902B2 · Euteneuer et al. · 2017 [cited by applicant]
US 9757279B2 · Kahook · 2017 [cited by applicant]
US 9820883B2 · Berlin · 2017 [cited by applicant]
US 9820885B2 · Sorensen et al. · 2017 [cited by applicant]
US 9855167B2 · Badawi et al. · 2018 [cited by applicant]
US 9872799B2 · Kahook · 2018 [cited by applicant]
US 9895258B2 · Badawi et al. · 2018 [cited by applicant]
US 9999544B2 · Baerveldt et al. · 2018 [cited by applicant]
US 10085885B2 · Baerveldt et al. · 2018 [cited by applicant]
US 10123905B2 · Mittelstein et al. · 2018 [cited by applicant]
US 10179066B2 · Badawi et al. · 2019 [cited by applicant]
US 10327947B2 · Kahook · 2019 [cited by applicant]
US 10695218B1 · Ianchulev · 2020 [cited by applicant]
US 10905591B1 · Ianchulev · 2021 [cited by applicant]
US 11419762B2 · Ianchulev · 2022 [cited by applicant]
US 20030236484A1 · Lynch et al. · 2003 [cited by applicant]
US 20060047263A1 · Tu et al. · 2006 [cited by applicant]
US 20060241580A1 · Mittelstein et al. · 2006 [cited by applicant]
US 20070073275A1 · Conston et al. · 2007 [cited by applicant]
US 20080228127A1 · Burns et al. · 2008 [cited by applicant]
US 20090287143A1 · Line · 2009 [cited by applicant]
US 20090287233A1 · Huculak · 2009 [cited by applicant]
US 20100262174A1 · Sretavan et al. · 2010 [cited by applicant]
US 20100280317A1 · Silvestrini et al. · 2010 [cited by applicant]
US 20120035524A1 · Silvestrini · 2012 [cited by applicant]
US 20120083727A1 · Barnett · 2012 [cited by applicant]
US 20120191064A1 · Conston et al. · 2012 [cited by applicant]
US 20130184631A1 · Pinchuk · 2013 [cited by applicant]
US 20130253402A1 · Badawi et al. · 2013 [cited by applicant]
US 20130253403A1 · Badawi et al. · 2013 [cited by applicant]
US 20130289545A1 · Baerveldt et al. · 2013 [cited by applicant]
US 20150045820A1 · Kahook · 2015 [cited by applicant]
US 20150080783A1 · Berlin · 2015 [cited by applicant]
US 20160100980A1 · Badawi et al. · 2016 [cited by applicant]
US 20160287438A1 · Badawi et al. · 2016 [cited by applicant]
US 20170252212A1 · Euteneuer et al. · 2017 [cited by applicant]
US 20170258636A1 · Baerveldt et al. · 2017 [cited by applicant]
US 20170367890A1 · Kahook · 2017 [cited by applicant]
US 20180125712A1 · Sorensen et al. · 2018 [cited by applicant]
US 20180133056A1 · Kahook · 2018 [cited by applicant]
US 20180147088A1 · Liang et al. · 2018 [cited by applicant]
US 20180271699A1 · Badawi et al. · 2018 [cited by applicant]
US 20180289544A1 · Baerveldt et al. · 2018 [cited by applicant]
US 20180360655A1 · Berlin · 2018 [cited by applicant]
US 20180360661A1 · Kahook et al. · 2018 [cited by applicant]
US 20190060119A1 · Baerveldt et al. · 2019 [cited by applicant]
US 20190076296A1 · Ivantis · 2019 [cited by applicant]
US 20190142632A1 · Badawi et al. · 2019 [cited by applicant]
US 20200390601A1 · Ianchulev · 2020 [cited by applicant]
US 20200390602A1 · Ianchulev · 2020 [cited by applicant]
US 20210022919A1 · Ianchulev · 2021 [cited by applicant]
US 20210361484A1 · Ianchulev · 2021 [cited by applicant]
US 20220387215A1 · Filice · 2022 [cited by examiner]
US 20230000680A1 · Ianchulev et al. · 2023 [cited by applicant]
CN 101360523A · 2009 [cited by applicant]
CN 102824238A · 2012 [cited by applicant]
CN 103932840A · 2014 [cited by applicant]
CN 104203153A · 2014 [cited by applicant]
CN 105530875A · 2016 [cited by applicant]
CN 205359780U · 2016 [cited by applicant]
CN 107530190A · 2018 [cited by applicant]
CN 109195536A · 2019 [cited by applicant]
WO WO0064389A1 · 2000 [cited by applicant]
WO WO2011106781A1 · 2011 [cited by applicant]
WO WO2016044672A1 · 2016 [cited by applicant]
WO WO2016159999A1 · 2016 [cited by applicant]
WO WO2020120455A1 · 2020 [cited by applicant]
Sun, X. H., Wang, Y., & Meng, F. R. (2003). [Zhonghua yan ke za zhi] Chinese Journal of Ophthalmology, 39(8), 462-465. [English language abstract]. [cited by applicant]
U.S. Appl. No. 16/777,648, filed Jan. 30, 2020, US 20200390601 A1. [cited by applicant]
U.S. Appl. No. 17/178,066, filed Feb. 17, 2021, US 20210196516 A1. [cited by applicant]
U.S. Appl. No. 17/325,785, filed May 20, 2021, US 20210361484 A1. [cited by applicant]
PCT/US21/33335, May 20, 2021, WO 2021/236892. [cited by applicant]
U.S. Appl. No. 17/865,059, filed Jul. 14, 2022, US 20230009442 A1. [cited by applicant]
U.S. Appl. No. 17/940,380, filed Sep. 8, 2022, US 20230000680 A1. [cited by applicant]
U.S. Appl. No. 18/430,141, filed Feb. 1, 2024, US 20240164943 A1. [cited by applicant]
PCT/US2023/80677, Nov. 21, 2023, WO 2024/112747. [cited by applicant]
Cited By (2)
US 12,569,367 US 12,653,714